CASI icon

CASI Pharmaceuticals
CASI

Overview Fund Activity

30 hedge funds and large institutions have $2.55M invested in CASI Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 3 closing their positions.

Holders
30
Holders Change
-1
Holders Change %
-3.23%
% of All Funds
0.75%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
8
Reduced
5
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$144K
2
Deutsche Bank
2
Deutsche Bank
Germany
$37K
3
PIM
3
Penobscot Investment Management
Massachusetts
$31K
4
UBS Group
4
UBS Group
Switzerland
$4K
5
BFA
5
BlackRock Fund Advisors
California
$44K

Top Sellers

1
WSCM
1
Wellington Shields Capital Management
New York
$608K
2
Goldman Sachs
2
Goldman Sachs
New York
$0
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$398K
4
Citadel Advisors
4
Citadel Advisors
Florida
$0
5
MHP
5
Manatuck Hill Partners
Connecticut
$0
Name Market Value Shares Shares
Change 		Shares
Change %
FWM
26
Focused Wealth Management
New York
$0 45 – –
AG
27
Advisor Group
Arizona
$0 130 – –
NFG
28
Next Financial Group
Texas
$0 2 – –
CPIG
29
Chicago Partners Investment Group
Illinois
$0 27 – –
Creative Planning
30
Creative Planning
Kansas
$0 9 – –
IA
31
IFP Advisors
Florida
$0 3 +2 +200%
RFM
32
Royal Fund Management
Florida
$0 9 +9 New
Wells Fargo
33
Wells Fargo
California
$0 98 +18 +23%
1
2